日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial

广泛基因检测与有限基因检测在指导晚期实体瘤患者治疗中的应用:一项随机对照试验

Trédan, Olivier; Pouessel, Damien; Penel, Nicolas; Chabaud, Sylvie; Gomez-Roca, Carlos; Delord, Jean-Pierre; Pannier, Diane; Brahmi, Mehdi; Fabbro, Michel; Garcia, Marie-Eve; Larrieu-Ciron, Delphine; Ray-Coquard, Isabelle; Viala, Marie; Italiano, Antoine; Tosi, Diego; Cassier, Philippe; Dufresne, Armelle; Attignon, Valery; Boyault, Sandrine; Treilleux, Isabelle; Viari, Alain; Pérol, David; Blay, Jean Yves

Acceptance of external control arms by HTA agencies: a review of oncology submissions in France, England, Germany and Norway from 2021 to 2023

卫生技术评估机构对外部控制措施的接受度:对2021年至2023年法国、英国、德国和挪威肿瘤学申报的回顾

Monnereau, Matthias; Delord, Jean-Pierre; Michiels, Stefan; Le Tourneau, Christophe; Marque, Sebastien; Baschet, Louise; Filleron, Thomas

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden

一项随机、开放标签的 II 期研究,旨在评估纳武利尤单抗联合伊匹木单抗或纳武利尤单抗单药治疗高肿瘤突变负荷的晚期或转移性实体瘤患者的疗效。

Schenker, Michael; Burotto, Mauricio; Richardet, Martin; Ciuleanu, Tudor-Eliade; Gonçalves, Anthony; Steeghs, Neeltje; Schoffski, Patrick; Ascierto, Paolo A; Maio, Michele; Lugowska, Iwona; Lupinacci, Lorena; Leary, Alexandra; Delord, Jean-Pierre; Grasselli, Julieta; Tan, David S P; Friedmann, Jennifer; Vuky, Jacqueline; Tschaika, Marina; Konduru, Somasekhar; Vemula, Sai Vikram; Slepetis, Ruta; Kollia, Georgia; Pacius, Misena; Duong, Quyen; Huang, Ning; Doshi, Parul; Baden, Jonathan; Di Nicola, Massimo

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

一项针对既往接受过治疗的肝细胞癌患者的Ib/II期临床试验,比较了卡马替尼联合斯帕塔利珠单抗与单用斯帕塔利珠单抗的疗效。

Santoro, Armando; Assenat, Eric; Yau, Thomas; Delord, Jean-Pierre; Maur, Michela; Knox, Jennifer; Cattan, Stephane; Lee, Kyung-Hun; Del Conte, Gianluca; Springfeld, Christoph; Leo, Elisa; Xyrafas, Alexandros; Fairchild, Lauren; Mardjuadi, Feby; Chan, Stephen L

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial

抗TIGIT抗体Tiragolumab单药或联合Atezolizumab治疗晚期实体瘤患者:一项1a/1b期非随机对照试验

Kim, Tae Won; Bedard, Philippe L; LoRusso, Patricia; Gordon, Michael S; Bendell, Johanna; Oh, Do-Youn; Ahn, Myung-Ju; Garralda, Elena; D'Angelo, Sandra P; Desai, Jayesh; Hodi, F Stephen; Wainberg, Zev; Delord, Jean-Pierre; Cassier, Phillippe A; Cervantes, Andrés; Gil-Martin, Marta; Wu, Benjamin; Patil, Namrata S; Jin, Yanling; Hoang, Tien; Mendus, Diana; Wen, Xiaohui; Meng, Raymond; Cho, Byoung Chul

PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression

PPARγ激活调节腹腔巨噬细胞群的平衡,从而抑制卵巢肿瘤生长和肿瘤诱导的免疫抑制

Prat, Mélissa; Coulson, Kimberley; Blot, Clément; Jacquemin, Godefroy; Romano, Mathilde; Renoud, Marie-Laure; AlaEddine, Mohamad; Le Naour, Augustin; Authier, Hélène; Rahabi, Mouna Chirine; Benmoussa, Khaddouj; Salon, Marie; Parny, Mélissa; Delord, Jean-Pierre; Ferron, Gwenaël; Lefèvre, Lise; Couderc, Bettina; Coste, Agnès

RadioLigand Therapy with [(177)Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France

使用[(177)Lu]Lu-PSMA-617进行放射性配体治疗唾液腺癌:文献综述及法国首次同情用药

Terroir, Marie; Lamesa, Chloé; Krim, Mehdi; Vija, Lavinia; Texier, Jean-Sébastien; Cassou-Mounat, Thibaut; Delord, Jean-Pierre; Vallot, Delphine; Courbon, Frédéric

Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer

开发和外部验证用于预测头颈癌的PET放射组学模型

Noortman, Wyanne A; Aide, Nicolas; Vriens, Dennis; Arkes, Lisa S; Slump, Cornelis H; Boellaard, Ronald; Goeman, Jelle J; Deroose, Christophe M; Machiels, Jean-Pascal; Licitra, Lisa F; Lhommel, Renaud; Alessi, Alessandra; Woff, Erwin; Goffin, Karolien; Le Tourneau, Christophe; Gal, Jocelyn; Temam, Stéphane; Delord, Jean-Pierre; van Velden, Floris H P; de Geus-Oei, Lioe-Fee

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer

一项评估比美替尼(MEK162)联合帕尼单抗治疗RAS突变型或野生型转移性结直肠癌疗效和安全性的Ib/II期研究

Van Cutsem, Eric; Yaeger, Rona; Delord, Jean-Pierre; Tabernero, Josep; Siu, Lillian L; Ducreux, Michel; Siena, Salvatore; Elez, Elena; Kasper, Stefan; Zander, Thomas; Steeghs, Neeltje; Murphy, Danielle; Edwards, Michelle; Wainberg, Zev A

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

一项评估 Alpelisib 联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌患者的 1b/2 期研究

Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George Jr; Solomon, Benjamin; Lim, Darren Wan-Teck; Hong, Ruey-Long; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre